Construction of the plant will start in 2025 with first manufacturing anticipated to be in 2027
The Board of Directors of Tata Chemicals Europe Limited (TCEL), an entirely-owned subsidiary of Tata Chemicals Limited has at its Board Meeting held on November 12, 2024 taken into consideration and approved the proposal of capital investment of £60 million (Rs. 655 crore) to build a 1, 80,000 tons per annum pharmaceutical grade sodium bicarbonate plant in Northwich, United Kingdom.
This new plant will triple TCEL’s production ability of pharmaceutical grade sodium bicarbonate within the UK. Further, as a part of the restructuring operations to facilitate this investment, the Board of TCEL has approved the proposal to cease chemical production at its loss-making Lostock plant by the end of January 2025, subject too completion of employee consultation as required below local law.
The construction of the plant will commence in 2025 with first manufacturing anticipated to be in 2027. Using a patented procedure, the brand new plant will use carbon dioxide captured from energy generation emissions as a key raw material and will meet developing call for for high grade sodium bicarbonate from pharmaceutical manufacturers to be used in medicines and hemodialysis.
